20050503
 Biovail Corp.: Kos Pharmaceuticals Will Buy Hypertension-Drug Businesses   The Wall Street Journal,  May 4, 2005  Biovail Corp. will cut its work force by 20% and sell certain hypertension-drug assets in an effort to improve profits at the company's U.S. commercial business.   
